Fidelity Investments’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.7K Buy
2025
Q1
$5.41K Sell
2024
Q4
$17.7K Buy
2024
Q3
$18.1K Buy
2024
Q2
$9.56K Buy
2024
Q1
$7.34K Buy
2023
Q4
$3.97K Buy
2023
Q3
$2.75K Sell
2023
Q2
$5.47K Buy
2023
Q1
$1.55K Buy